News items Aura Timen appointed head of the Department of Primary and Community Care
10 December 2021

Prof. Dr. Aura Timen has been appointed head of the Department of Primary and Community Care of Radboud university medical center as of April 15, 2022. On that date, she will also be appointed Professor of Primary and Community Care by the Executive Board of Radboud University.

Aura Timen has been head of the Dutch National Coordination Center for Infectious Disease Control (LCI) at the National Institute for Public Health and the Environment (RIVM) since 2011. As an expert in the field of infectious diseases, she is closely involved in the fight against COVID-19, providing the national media with substantive interpretation of the COVID-19 pandemic, therefore becoming a nationally well-known expert. She is also the scientific secretary of the Outbreak Management Team, which gives advice about COVID-19 to the Dutch government.

Aura Timen (Cluj-Napoca (Romania), 1966) studied Medicine at Vrije Universiteit Amsterdam, she graduated in 1995. She is registered as a medical specialist Arts Maatschappij en Gezondheid (doctor society and health), profile infectious disease control and trainer in this field. She received her doctorate at Radboud University for her thesis 'Outbreak Management: towards a model for the next crisis'. She has extensive research experience in the field of transferable disease control, both in the Netherlands and internationally.

Timen actively participates in several national and international networks. Until 2019, she was Chair of the Infectious Disease Control Section of the European Public Health Association (EUPHA) and is currently a member of the Advisory Forum of the European Centre for Disease Prevention and Control (ECDC). She has also chaired the WHO Collaborating Centre for Infectious Disease Preparedness and IHR monitoring and response since 2017. In addition, she is holding the position of Professor 'Responses to communicable diseases in global health' at Vrije Universiteit Amsterdam until June 2023.

Jan Smit, Dean and Vice Chair of the Executive Board of Radboud university medical center: "With Aura Timen we are happy to introduce an expert who fits our mission for the future perfectly. Her expertise in public health, infectious diseases and prevention is of great value and importance to Radboud university medical center. She will focus on the further development of the Department of Primary and Community Care and the design of transmural and integrated care, from within all disciplines of Primary and Community Care, Radboud university medical center, primary care and the public domain."

Aura Timen: "COVID-19 is not the exclusive domain of one discipline, but rather requires an approach where knowledge and innovation must come together in a multidisciplinary and transdisciplinary manner. The experience with COVID-19 inspired me to take this step: to work on research and education for the integrated care of tomorrow, to be prepared for future challenges and crises. And no better place to do this than at the Department of Primary and Community Care at Radboud university medical center, where my ambition is to strengthen the connection of primary care with the clinic and public care."

About the Department of Primary and Community Care

The mission of the department of Primary and Community Care is ‘to have a significant impact on health - personalized healthcare in context’ and consists of three units: training, education and research. The department actively participates in research, undergraduate and graduate programs, with a focus on general practice, education research, elderly care, gender, social medicine, public health, intellectual disabilities medicine, and prevention.

More information

Dennis Verschuren

woordvoerder / persvoorlichter

neem contact op

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items

The future of laboratory animal research More attention to living conditions of laboratory animals

16 May 2022

On May 9, a meeting took place at the Radboudumc as a result of the launch of the Dutch Transparency Agreement on Animal Testing. The Radboudumc is one of the twenty signatories and has thus committed itself to openly and transparently communicate its vision and policy with regard to animal testing.

read more

Only half of young female cancer patients get a chance to preserve their fertility Receiving fertility care in cancer improves quality of life and prevents regret

13 May 2022

Of young female cancer patients, only half receives a referral to a gynecologist for a discussion about preserving her fertility, such as by freezing eggs. Researchers from the Radboudumc show that receiving this care leads to a better quality of life and less decision conflict  and regret.

read more

Arthritis drug use to limit antibiotics in blood cancer Drug Anakinra strengthens gut lining and inhibits inflammation

12 May 2022

Researchers from the University of Adelaide and the Radboud University Medical Center have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood cancer, including leukemia, lymphoma and myeloma.

read more

Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling

11 May 2022

Bart Smeets, Jitske Jansen and collegues, theme Renal disorders published this article in the Human Development.

read more